The Bill & Melinda Gates Foundation, the world’s largest philanthropy, decided about five years ago that instead of just giving out grants to researchers and hoping for the best, it sometimes made more sense to invest in startups. That way, the Seattle-based foundation could put some of its $43.5 billion to work with entrepreneurs developing high-impact vaccines, diagnostics, and drugs... Read More
Walk into any biomedical lab these days, and chances are you’ll see Illumina’s orange logo. Many scientists, diagnostics makers, physicians, and Wall Street analysts look upon the dominant maker of DNA sequencing machines with a mix of respect, fear, and awe. Much like Intel became the company that sparked so much of the computer revolution, Illumina has risen to prominence... Read More
This is the cold, dreary, snowy time of year when all the geeky kids in genomics flock to a remote island off the Florida Gulf Coast. The boys, and they are mostly boys, will hear a lot of marketing hype about the whiz-bang new tools being developed for biology. They’ll hear a few nitty-gritty technical talks from scientists doing exciting... Read More
People want quality biotech journalism. The response from subscribers in the first two weeks of Timmerman Report has exceeded my most optimistic expectations. A half-dozen journalists covered the debut. Wade Roush at the Knight Science Journalism Fellowships at MIT and Theral Timpson at Mendelspod deserve special thanks. Readers who know what kind of beating traditional journalism has taken over the... Read More
Intelligent MDx, the Waltham, Mass.-based maker of several molecular diagnostic tests for infectious disease that run on instruments from Abbott Laboratories, has laid off its staff and is winding down operations, the Timmerman Report has learned from sources close to the situation.
Questions and comments have been pouring in here at Timmerman Report headquarters ever since the site debuted on Feb. 2. The early days have been nothing short of spectacular in my view. I’ll have more to say about that shortly. But for now, there are some of answers to the questions that keep popping up: Q: What do you cover?
The Timmerman Report Gives You Consistent In-Depth Reporting on Biotechnology. Get Your Edge.